![Monic Stuart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Monic Stuart
Directeur Technique/Scientifique/R&D chez MARKER THERAPEUTICS, INC.
Profil
Monic Stuart is currently the Chief Medical Officer at Marker Therapeutics, Inc. Prior to this, he held the position of Senior Medical Director at Genentech, Inc. from 2004 to 2009.
He then served as the Vice President-Clinical Development at Geron Corp.
from 2011 to 2012.
Dr. Stuart completed his graduate degree at The Johns Hopkins University and holds undergraduate and doctorate degrees from the University of North Carolina at Chapel Hill.
Postes actifs de Monic Stuart
Sociétés | Poste | Début |
---|---|---|
MARKER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 08/05/2023 |
Anciens postes connus de Monic Stuart
Sociétés | Poste | Fin |
---|---|---|
GERON CORPORATION | Directeur Technique/Scientifique/R&D | 01/02/2012 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Formation de Monic Stuart
University of North Carolina at Chapel Hill | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
GERON CORPORATION | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |